Wafture Pharmaceuticals Private Limited - Company Profile

It is a food and beverages private limited company based in Hyderabad, Telangana, India, established in 2017.
2017 Hyderabad, Telangana, India Struck Off
Last Updated:
About Wafture Pharmaceuticals Private Limited

Wafture Pharmaceuticals Private Limited, a struck off private limited company, was established on 29 December 2017 in Hyderabad, Telangana, India. Engaging in artificial fibres within the food and beverages sector, it holds CIN: U24304TG2017PTC121527. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

It upholds a active non-compliant status. Its leadership includes Venkata Suryanarayana Chennupalli (Director), Venkatareddy Gangula (Director). It is based at H No.12-5-65 & 65/1, Shop No.1 Sardar Pater Nagar, Moosapet, Hyderabad, Telangana, 500018.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24304TG2017PTC121527

  • Registration Number

    121527

  • Incorporation Date

    29 December 2017

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 8 Year, 5 Months
Company report

Wafture Pharmaceuticals Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Wafture Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Wafture Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Venkata Suryanarayana Chennupalli Director 29 Dec 2017 Current
Venkatareddy Gangula Director 29 Dec 2017 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Wafture Pharmaceuticals.

Enhance accessibility to Wafture Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Wafture Pharmaceuticals revenue growth over time
Wafture Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Wafture Pharmaceuticals?

Unlock access to Wafture Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Wafture Pharmaceuticals?

Unlock and access historical data on people associated with Wafture Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Wafture Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Wafture Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Wafture Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    The activity Venkata Suryanarayana Chennupalli was appointed as a Director was appointed as a Director on 29 Dec 2017 & has been associated with this company since 8 years 5 months . was completed.

  • Director Appointment

    Venkatareddy Gangula was appointed as a Director was appointed as a Director on 29 Dec 2017 & has been associated with this company since 8 years 5 months . was recorded as a recent event.

  • Company Incorporation

    Progress on Wafture Pharmaceuticals Private Limited was registered on 29 Dec 2017 with Roc Hyderabad & aged 8 years 5 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Wafture Pharmaceuticals Private Limited?

The CIN of Wafture Pharmaceuticals Private Limited is U24304TG2017PTC121527.

Where is Wafture Pharmaceuticals Private Limited headquartered?

Wafture Pharmaceuticals Private Limited is headquartered at H No.12-5-65 & 65/1, Shop No.1 Sardar Pater Nagar, Moosapet, Hyderabad, Telangana, 500018.

When was Wafture Pharmaceuticals Private Limited incorporated?

Wafture Pharmaceuticals Private Limited was incorporated on 29 December 2017.

Who are the current directors of Wafture Pharmaceuticals Private Limited?

The current directors of Wafture Pharmaceuticals Private Limited are

What is the primary industry of Wafture Pharmaceuticals Private Limited?

The primary industry of Wafture Pharmaceuticals Private Limited is Food And Beverages.

Is Wafture Pharmaceuticals Private Limited a listed company?

Wafture Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Wafture Pharmaceuticals Private Limited?

The authorized capital of Wafture Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Wafture Pharmaceuticals Private Limited?

The compliance status of Wafture Pharmaceuticals Private Limited is Active Non-Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available